Blood Donation Eligibility in Secondary Polycythemia

Core Rationale for Donor Exclusion

Secondary polycythemia results from hypoxia-driven processes, including chronic lung disease, right-to-left cardiopulmonary shunts, and high-altitude habitation, making individuals medically unsuitable as voluntary blood donors 1, 2, 3, 4
Hypoxia-independent causes of secondary polycythemia, such as malignant tumors producing erythropoietin autonomously, also disqualify individuals from blood donation based on standard donor eligibility criteria 1, 2, 4
Underlying conditions, including chronic pulmonary disease, cardiovascular disease with shunting, or malignancy, independently disqualify individuals from blood donation 5, 6

Phlebotomy in patients with secondary polycythemia risks iron depletion, decreased oxygen-carrying capacity, and increased stroke risk 7, 2
Removing blood from patients with secondary polycythemia could precipitate acute decompensation, particularly in those with cyanotic congenital heart disease or severe COPD 7, 2
Aggressive or repeated routine phlebotomies in secondary polycythemia are contraindicated except in rare circumstances, such as hemoglobin >20 g/dL or hematocrit >65% with hyperviscosity symptoms after adequate hydration 7, 2

Blood components from donors with underlying chronic pulmonary disease, cardiovascular disease, or malignancy may not meet quality standards for transfusion products 5, 6
Patients with secondary polycythemia often require chronic transfusion support themselves and represent a logistical challenge to blood bank capability 5, 6